Vitaeris

Monoclonal Antibodies (MAbs) for inflammatory diseases

placeVancouver, British Columbia, Canada calendar_todayFounded 2016 groups11 employees language vitaerisbio.com

Innovation

13 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,461 times.

YearFilings
20131
20163
20181
20192
20205
20216
20222
20232
20241
20251

Investor mix

2 investors on record; lead investors include HBM Healthcare Investments.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon